Miracell to Participate in Singapore Medical Fair 2022 Booth
Introducing the “SMART M-CELL 2” Stem Cell Extraction System
【Health Digest | Reporter Choi Min-young】 Stem cell specialist Miracell (CEO Shin Hyun-soon) will showcase its stem cell extraction system, the “SMART M-CELL 2,” at the large-scale medical device exhibition “MEDICAL FAIR ASIA 2022,” held at Marina Bay Sands in Singapore from August 31st to September 2nd.
The newly unveiled “SMART M-CELL 2” is an automated system capable of selectively isolating, extracting, and concentrating stem cells in just 17 minutes.
Its key technology is its ability to maximize cell viability. This system automatically adjusts the RPM and angle of the separation vessel,
reducing friction between vessels to minimize cell damage. Its closed system, which prevents air contact,
is a bio-digital device equipped with LEDs that stimulate cell activity.
Because it utilizes autologous bone marrow or blood, it is safe from immune rejection and side effects, and is used in hospitals and clinics nationwide, including university hospitals.
According to the company, it has secured GMP, ISO 13485, ISO 9001, and European CE certifications, as well as 22 domestic and international patents for cell extraction technology,
securing its source technology for stem cell technology. Following certification as a New Health Technology and Government Innovation Product, it recently completed FDA registration.
CEO Shin Hyun-soon stated, “With the attention of many medical professionals and healthcare professionals at this year’s Singapore Medical Fair,
Smart Mcell 2, a core system in regenerative medicine, is drawing closer to entering the global market.”
Meanwhile, Miracell plans to participate in the ISAPS International Congress of Aesthetic Plastic Surgery, held in Istanbul, Turkey, from September 20th, and the IMCAS International Congress of Aesthetic Plastic Surgery, held in Bangkok, Thailand, from September 29th, to promote its advanced stem cell extraction system and expand exports.